Adversarial Defense Engine

Coastal Physical Therapy Group — $48M Revenue — Phase 2: Diligence

Quality of Revenue (QoR), Coding, and EBITDA Normalization

$7.70M
Reported EBITDA
$620K
Provider Comp Normalization (Dr. Santos)
$180K
Locum Tenens Costs
$95K
One-Time EMR Migration Costs
$140K
Malpractice Insurance True-Up
$-120K
Below-Market Rent (Founder-Owned Building)
$0
Reimbursement Rate Change Impact
$0
Coding Intensity Audit Adjustment
$320K
Pro Forma Add-On #3 (Sports Medicine)
$95K
Non-Cash Stock Compensation
$-280K
Customer Loss (Q4 2025 — Employer Group)
$8.75M
Adjusted EBITDA
Line ItemSeller AmountShadow AmountVarianceShadow Note
Reported EBITDA$7.70M$7.70M--Per trailing twelve months ending December 2025
Provider Comp Normalization (Dr. Santos)$620K$420K+$200KReplacement is $350K in this market, not $280K. Market data supports $130K add-back, not $200K. Variance: $200K.
Locum Tenens Costs$180K$0+$180KRecurs every summer — 3 of 4 years had locum costs. Not non-recurring. Full reversal of add-back. Variance: $180K.
One-Time EMR Migration Costs$95K$95K--Confirmed one-time. Supportable add-back.
Malpractice Insurance True-Up$140K$140K--Timing adjustment, supportable.
Below-Market Rent (Founder-Owned Building)($120K)($185K)+$65KMedical office comps in Orlando: $26-$30/sqft. Normalize to $27/sqft. Variance: $65K.
Reimbursement Rate Change Impact$0($280K)+$280KMedicare outpatient PT cap restored effective Jan 2026. $280K annual impact on Medicare volume. Should be in run-rate. Variance: $280K.
Coding Intensity Audit Adjustment$0($140K)+$140KCPT code distribution shows 15% higher E&M coding than PT specialty benchmark. Recoupment exposure estimated at $140K. Variance: $140K.
Pro Forma Add-On #3 (Sports Medicine)$320K$210K+$110KTrailing 6-month annualized is $210K, not peak quarter extrapolation. Variance: $110K.
Non-Cash Stock Compensation$95K$95K--Standard non-cash add-back. Supportable.
Customer Loss (Q4 2025 — Employer Group)($280K)($350K)+$70KAnnualized margin impact higher than seller calculated. Full-year impact is $350K, not $280K partial-year. Variance: $70K.
Adjusted EBITDA$8.75M$7.71M$1.04M
Seller Adjusted EBITDA: $8.75M|Shadow EBITDA: $7.71M|Variance: $1045K|At 11.5x: $12.0M overpayment risk